Definitive Healthcare Corp.
DH Nasdaq· Services-Prepackaged Software
Last close · Oct 23, 2026
$1.08
KIRA · Stoqly’s AI analyst, in plain words
- Definitive Healthcare Corp. had $242M of revenue in fiscal 2025, down 4.2% on the year before. Over five years, revenue changed +15.3% a year on average.
- Its operating margin was −92.9%, up 189.0 pts: of every 100 in sales, about −93 is left after running the business.
- Definitive Healthcare Corp. lost $139M in fiscal 2025.
- Free cash flow was $37.1M in fiscal 2025, 15.3% of revenue.
- Definitive Healthcare Corp. returned $49.5M to shareholders in fiscal 2025, 133% of free cash flow. The diluted share count fell 8.6%.
- Definitive Healthcare Corp. has $14.6M more cash than debt.
Market cap
$114M
P/E
—
Revenue
$242M
Net income
−$139M
Free cash flow
$37.1M
Operating margin
−92.9%
Definitive Healthcare Corp. in 30 seconds · fiscal 2025
Are sales growing?
−4.2%
No. Sales fell 4.2% last year.
Does it make a profit?
−57.5%
No. It lost money last year.
Does profit turn into cash?
15.3%
Yes. 15.3% of sales ends up as free cash.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Definitive Healthcare Corp. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- Definitive Healthcare Corp.
- CIK
- 0001861795
Definitive Healthcare Corp. · DH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $166M | $223M | $251M | $252M | $242M |
| Revenue growth | 40.4% | 34.0% | 12.9% | 0.3% | −4.2% |
| Gross margin | 75.5% | 80.9% | 81.1% | 78.3% | 75.9% |
| Operating margin | −16.4% | −19.8% | −131.2% | −281.8% | −92.9% |
| Net income | −$17.8M | −$7.2M | −$202M | −$413M | −$139M |
| Net margin | −10.7% | −3.2% | −80.5% | −163.8% | −57.5% |
| Diluted EPS | −$0.19 | −$0.07 | −$1.79 | −$3.54 | −$1.30 |
| Cash | |||||
| Cash from operations | $25.2M | $35.6M | $41.2M | $58.2M | $53.8M |
| Capital expenditure | $6.7M | $8.3M | $3.0M | $12.3M | $16.7M |
| Free cash flow | $18.5M | $27.3M | $38.2M | $45.9M | $37.1M |
| FCF margin | 11.1% | 12.2% | 15.2% | 18.2% | 15.3% |
| Share buybacks | — | $0.0M | $0.0M | $22.4M | $49.5M |
| Share count change | — | 10.0% | 11.5% | 3.4% | −8.6% |
| Debt and strength | |||||
| Cash and short-term investments | $387M | $332M | $308M | $290M | $181M |
| Debt incl. finance leases | $273M | $266M | $258M | $244M | $166M |
| Shareholders' equity | $1.5B | $1.5B | $1.2B | $607M | $379M |
| Current ratio | 3.6x | 2.9x | 2.3x | 2.3x | 1.6x |
| Interest coverage | −1.1x | −3.9x | −21.7x | −47.9x | −19.9x |
| Returns and quality | |||||
| Return on capital | −1.6% | −2.5% | −22.7% | −100.1% | −48.6% |
| Return on equity | −1.3% | −0.5% | −15.1% | −45.7% | −28.2% |
| Piotroski F-score | 6 | 6 | 4 | 3 | 5 |
| Altman Z'' | 3.4 | 3.1 | 1.2 | −3.7 | −3.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Definitive Healthcare Corp. · DH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.08 a share, the company is worth $114M.
Source: SEC EDGAR XBRL filings (CIK 0001861795). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.